Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Petter Bjornstad

Concepts (341)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Diabetic Nephropathies
62
2023
234
21.540
Why?
Diabetes Mellitus, Type 1
67
2022
3252
9.610
Why?
Diabetes Mellitus, Type 2
47
2024
2094
8.120
Why?
Glomerular Filtration Rate
45
2024
604
6.160
Why?
Uric Acid
23
2022
148
4.920
Why?
Kidney
38
2024
1188
4.710
Why?
Insulin Resistance
17
2024
1072
3.970
Why?
Albuminuria
17
2022
164
2.980
Why?
Renal Insufficiency, Chronic
13
2023
486
2.790
Why?
Metformin
10
2023
276
2.750
Why?
Coronary Artery Disease
11
2022
607
2.750
Why?
Pediatric Obesity
7
2023
488
2.560
Why?
Diabetic Angiopathies
9
2019
244
2.550
Why?
Bariatric Surgery
5
2020
161
2.460
Why?
Obesity, Morbid
5
2020
197
2.360
Why?
Glycopeptides
10
2021
43
2.350
Why?
Biomarkers
28
2022
3408
2.320
Why?
Vascular Calcification
6
2022
107
2.220
Why?
Renal Insufficiency
5
2022
137
2.120
Why?
Hemodynamics
18
2022
1012
2.120
Why?
Renin-Angiotensin System
10
2021
72
2.040
Why?
Hypoglycemic Agents
16
2022
1012
1.930
Why?
Adolescent
52
2024
17837
1.810
Why?
Cardiovascular Diseases
13
2021
1727
1.620
Why?
Humans
133
2024
114654
1.520
Why?
Sodium-Glucose Transporter 2
8
2022
17
1.420
Why?
Male
82
2024
55579
1.330
Why?
Diabetic Ketoacidosis
2
2022
159
1.330
Why?
Calcinosis
4
2015
242
1.330
Why?
Young Adult
36
2024
10465
1.300
Why?
Creatinine
12
2022
425
1.270
Why?
Disease Progression
16
2021
2380
1.260
Why?
Female
77
2024
59488
1.240
Why?
Diabetic Cardiomyopathies
4
2020
34
1.220
Why?
Risk Factors
33
2021
8631
1.180
Why?
Hypertension
9
2021
1056
1.110
Why?
Sex Characteristics
5
2020
640
1.070
Why?
Adiposity
4
2020
457
1.060
Why?
Exercise Tolerance
3
2017
213
1.050
Why?
Atherosclerosis
4
2018
341
1.030
Why?
Adult
47
2024
30542
1.010
Why?
Fructose
4
2021
100
1.000
Why?
Apolipoproteins B
2
2015
41
0.980
Why?
Uromodulin
3
2019
21
0.960
Why?
Adiponectin
2
2016
213
0.940
Why?
Hyperuricemia
6
2021
43
0.940
Why?
Glucosides
7
2022
36
0.930
Why?
Benzhydryl Compounds
7
2022
60
0.910
Why?
Obesity
10
2021
2508
0.890
Why?
Follow-Up Studies
15
2021
4411
0.890
Why?
Vasopressins
2
2021
56
0.890
Why?
Middle Aged
43
2022
26732
0.870
Why?
Diabetic Retinopathy
4
2021
149
0.860
Why?
Vascular Stiffness
6
2021
407
0.860
Why?
Dyslipidemias
5
2021
154
0.850
Why?
Kidney Tubules
2
2021
107
0.840
Why?
Hyperoxia
1
2024
99
0.840
Why?
Child
25
2023
18407
0.830
Why?
Acute Kidney Injury
4
2022
637
0.820
Why?
Blood Glucose
9
2019
1826
0.820
Why?
Case-Control Studies
13
2020
3003
0.820
Why?
Arterioles
2
2019
39
0.800
Why?
Hyperglycemia
4
2022
291
0.780
Why?
Prognosis
10
2021
3327
0.750
Why?
Glucagon-Like Peptide-1 Receptor
5
2022
72
0.720
Why?
Oxygen Consumption
3
2017
588
0.700
Why?
Blood Pressure
9
2022
1538
0.700
Why?
Dried Blood Spot Testing
2
2018
71
0.690
Why?
Triglycerides
3
2022
467
0.680
Why?
Oxygen
2
2024
854
0.680
Why?
Iohexol
2
2020
16
0.670
Why?
Vascular Resistance
6
2020
337
0.660
Why?
Cyclic GMP
1
2019
80
0.650
Why?
Cross-Sectional Studies
15
2019
4407
0.640
Why?
Cystatin C
6
2017
62
0.640
Why?
Lipid Metabolism Disorders
1
2018
2
0.640
Why?
Coronary Vessels
3
2017
227
0.630
Why?
Weight Reduction Programs
1
2019
94
0.620
Why?
Gastric Bypass
1
2020
92
0.620
Why?
Leptin
2
2017
210
0.620
Why?
Longevity
5
2019
137
0.610
Why?
Incidence
9
2021
2312
0.600
Why?
Cardiotonic Agents
1
2018
119
0.600
Why?
Hemofiltration
1
2018
31
0.600
Why?
Sodium Bicarbonate
1
2018
40
0.600
Why?
Cholesterol, HDL
2
2015
183
0.590
Why?
Ventricular Function, Left
3
2020
467
0.580
Why?
Kidney Diseases
2
2018
350
0.580
Why?
Cohort Studies
15
2019
4895
0.560
Why?
Blood Vessels
1
2018
180
0.560
Why?
Aorta
2
2019
386
0.550
Why?
Glucose
4
2022
896
0.550
Why?
Kidney Failure, Chronic
3
2021
489
0.540
Why?
Nutrition Surveys
1
2017
224
0.530
Why?
Up-Regulation
2
2016
807
0.530
Why?
Cholesterol, LDL
2
2014
307
0.530
Why?
Kidney Function Tests
4
2022
140
0.500
Why?
Renal Circulation
3
2021
53
0.490
Why?
Hypoxia
2
2020
957
0.480
Why?
Pregnancy Outcome
1
2017
337
0.480
Why?
Angiotensin II Type 2 Receptor Blockers
1
2014
7
0.470
Why?
Echocardiography
2
2018
553
0.460
Why?
Dietary Supplements
1
2018
460
0.460
Why?
Overweight
2
2018
471
0.450
Why?
Goals
1
2015
147
0.440
Why?
Patient Care Planning
1
2014
139
0.440
Why?
Heart Failure
3
2021
1945
0.430
Why?
Canada
6
2019
322
0.430
Why?
Aged
23
2022
19068
0.430
Why?
Vasoconstriction
3
2020
177
0.420
Why?
Lipids
2
2022
580
0.420
Why?
Fasting
1
2014
240
0.410
Why?
Chitinase-3-Like Protein 1
2
2022
17
0.410
Why?
Contrast Media
1
2015
345
0.410
Why?
Histidine
2
2022
57
0.400
Why?
Glucose Clamp Technique
5
2020
181
0.380
Why?
Clinical Trials as Topic
6
2022
931
0.380
Why?
Angiotensin II
3
2020
87
0.370
Why?
Guideline Adherence
1
2015
490
0.360
Why?
Body Mass Index
8
2019
1958
0.360
Why?
Pilot Projects
5
2021
1373
0.360
Why?
Sodium
3
2022
183
0.350
Why?
Lipocalin-2
2
2022
61
0.350
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
373
0.350
Why?
Prospective Studies
8
2020
6217
0.330
Why?
Insulin
5
2024
2078
0.330
Why?
Albumins
2
2022
89
0.320
Why?
Kidney Glomerulus
2
2021
100
0.310
Why?
Diabetes Complications
2
2021
211
0.290
Why?
Metabolic Syndrome
3
2021
321
0.290
Why?
Treatment Outcome
10
2019
9087
0.290
Why?
Diabetes Mellitus
3
2021
900
0.270
Why?
Pulse Wave Analysis
4
2021
207
0.270
Why?
Severity of Illness Index
3
2021
2537
0.270
Why?
Age Factors
7
2019
2894
0.270
Why?
Colorado
4
2017
4099
0.260
Why?
Time Factors
6
2018
6115
0.260
Why?
Hydrogen-Ion Concentration
2
2018
511
0.250
Why?
Predictive Value of Tests
4
2018
1796
0.250
Why?
Early Diagnosis
2
2017
217
0.240
Why?
Lipoproteins
2
2022
159
0.230
Why?
Renin
2
2022
31
0.230
Why?
Body Composition
2
2020
590
0.230
Why?
Canagliflozin
2
2021
8
0.220
Why?
Consensus
2
2022
537
0.210
Why?
Dipeptidyl-Peptidase IV Inhibitors
2
2020
44
0.200
Why?
Malates
1
2022
5
0.200
Why?
Fumarates
1
2022
10
0.200
Why?
Carboxylic Acids
1
2022
26
0.200
Why?
Drug Therapy, Combination
3
2019
951
0.200
Why?
Threonine
1
2022
40
0.200
Why?
Natriuresis
2
2019
8
0.200
Why?
Phenylalanine
1
2022
57
0.200
Why?
Pathology, Clinical
1
2022
32
0.200
Why?
Chemokine CCL2
1
2022
105
0.190
Why?
Leucine
1
2022
102
0.190
Why?
Glycine
1
2022
152
0.190
Why?
Arizona
1
2021
68
0.190
Why?
Tryptophan
1
2022
136
0.190
Why?
Glucagon-Like Peptide 1
1
2022
101
0.180
Why?
Receptors, Vasopressin
1
2021
18
0.180
Why?
Longitudinal Studies
4
2017
2387
0.180
Why?
Osmolar Concentration
2
2018
173
0.180
Why?
p-Aminohippuric Acid
1
2020
6
0.180
Why?
Diuretics
1
2021
66
0.180
Why?
Multivariate Analysis
2
2014
1430
0.180
Why?
Furosemide
1
2020
32
0.180
Why?
Interleukin-18
1
2022
219
0.180
Why?
Japan
5
2017
86
0.180
Why?
Natriuretic Peptide, Brain
1
2021
94
0.180
Why?
Nephrosis
1
2020
4
0.180
Why?
Asymptomatic Diseases
2
2019
75
0.180
Why?
Calcium Channel Blockers
1
2021
114
0.180
Why?
Diabetic Neuropathies
1
2021
79
0.170
Why?
Age of Onset
1
2021
446
0.170
Why?
Endothelin Receptor Antagonists
1
2020
58
0.170
Why?
Glycolysis
1
2021
227
0.170
Why?
Mineralocorticoid Receptor Antagonists
1
2020
38
0.170
Why?
Sodium-Glucose Transporter 1
1
2019
10
0.170
Why?
Models, Biological
3
2016
1620
0.170
Why?
Body Water
1
2019
19
0.170
Why?
Diabetic Foot
1
2019
22
0.170
Why?
Glycosides
1
2019
33
0.160
Why?
Glomerulonephritis
1
2019
45
0.160
Why?
Postmenopause
1
2021
303
0.160
Why?
Blood Chemical Analysis
1
2019
90
0.160
Why?
Body Temperature Regulation
1
2019
72
0.160
Why?
Weight Loss
2
2020
642
0.160
Why?
beta 2-Microglobulin
1
2018
45
0.160
Why?
Myocardial Contraction
1
2020
313
0.160
Why?
Carotid Intima-Media Thickness
1
2018
65
0.160
Why?
Amino Acids
1
2022
448
0.160
Why?
Microscopy, Polarization
1
2018
30
0.150
Why?
Biopsy
1
2022
1036
0.150
Why?
Hepatitis A Virus Cellular Receptor 1
1
2018
35
0.150
Why?
Allopurinol
1
2018
53
0.150
Why?
Pharmaceutical Preparations
1
2020
165
0.150
Why?
Obesity, Metabolically Benign
1
2017
4
0.150
Why?
Heat Stress Disorders
1
2018
40
0.150
Why?
Glucose Tolerance Test
2
2019
343
0.150
Why?
Prehypertension
1
2017
24
0.150
Why?
Glomerulosclerosis, Focal Segmental
1
2017
29
0.140
Why?
Hyperthermia, Induced
1
2018
65
0.140
Why?
Tomography, X-Ray Computed
2
2018
2285
0.140
Why?
Life Style
1
2019
430
0.140
Why?
Precision Medicine
1
2020
337
0.140
Why?
Running
1
2019
207
0.140
Why?
Urinary Calculi
1
2017
11
0.140
Why?
Peptide Fragments
1
2021
666
0.140
Why?
Cardiorespiratory Fitness
1
2017
35
0.140
Why?
Magnetic Resonance Angiography
1
2018
220
0.140
Why?
Regional Blood Flow
1
2018
424
0.140
Why?
Vasodilation
1
2020
419
0.140
Why?
Morbidity
1
2017
280
0.140
Why?
Survival Rate
2
2017
1644
0.140
Why?
Ventricular Dysfunction, Left
1
2020
358
0.140
Why?
Blood Banks
1
2016
40
0.140
Why?
Anti-Inflammatory Agents
1
2020
447
0.140
Why?
Hot Temperature
1
2018
302
0.130
Why?
Logistic Models
3
2017
1840
0.130
Why?
Animals
10
2021
31698
0.130
Why?
Vitreoretinopathy, Proliferative
1
2016
10
0.130
Why?
Heart Rate
1
2019
709
0.130
Why?
Linear Models
2
2017
768
0.130
Why?
Disease Models, Animal
4
2021
3531
0.130
Why?
Double-Blind Method
1
2020
1660
0.130
Why?
Software
1
2019
530
0.130
Why?
Echocardiography, Doppler
1
2016
92
0.130
Why?
Liver Diseases
1
2018
255
0.120
Why?
Risk Assessment
4
2019
2968
0.120
Why?
Absorptiometry, Photon
1
2016
224
0.120
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2016
179
0.120
Why?
Child, Preschool
2
2022
9111
0.120
Why?
Filtration
1
2015
59
0.120
Why?
Phenotype
1
2022
2796
0.120
Why?
Enzyme Inhibitors
1
2018
750
0.120
Why?
Apolipoproteins
1
2014
36
0.120
Why?
Blood Pressure Determination
1
2015
122
0.120
Why?
Purines
1
2015
159
0.110
Why?
Immunity, Innate
1
2019
720
0.110
Why?
Liver
2
2021
1637
0.110
Why?
Achievement
1
2014
54
0.110
Why?
Stress, Mechanical
1
2016
445
0.110
Why?
Randomized Controlled Trials as Topic
1
2019
1214
0.110
Why?
Research Design
1
2019
928
0.110
Why?
Exercise Test
1
2016
544
0.110
Why?
Primary Prevention
1
2015
172
0.110
Why?
Biomechanical Phenomena
1
2016
668
0.110
Why?
Aged, 80 and over
3
2018
6345
0.110
Why?
Adenosine Triphosphate
1
2015
430
0.110
Why?
Cholesterol
1
2014
367
0.100
Why?
Antihypertensive Agents
1
2016
429
0.100
Why?
RNA, Messenger
1
2019
2552
0.100
Why?
Feasibility Studies
1
2015
740
0.100
Why?
Testosterone
1
2015
343
0.100
Why?
Regression Analysis
1
2014
944
0.100
Why?
Ambulatory Care
1
2015
478
0.090
Why?
Societies, Medical
1
2015
663
0.090
Why?
United States
2
2017
12179
0.090
Why?
Vascular Diseases
1
2013
230
0.090
Why?
Gene Expression Regulation
1
2019
2319
0.090
Why?
Hematocrit
2
2021
87
0.090
Why?
Practice Guidelines as Topic
1
2017
1394
0.090
Why?
Registries
1
2016
1767
0.080
Why?
Inflammation
2
2021
2478
0.080
Why?
Prevalence
3
2019
2250
0.080
Why?
Reproducibility of Results
1
2015
2762
0.070
Why?
Sex Factors
3
2017
1715
0.070
Why?
Rats
1
2015
4958
0.070
Why?
Retrospective Studies
6
2019
12544
0.070
Why?
Pregnancy
1
2017
5517
0.060
Why?
Aging
1
2014
1618
0.060
Why?
Infant, Newborn
1
2014
5044
0.060
Why?
Mice
2
2021
14863
0.060
Why?
Cytokines
2
2021
1840
0.050
Why?
Benzbromarone
1
2022
2
0.050
Why?
Aldosterone
1
2022
42
0.050
Why?
Controlled Clinical Trials as Topic
1
2021
27
0.050
Why?
Clinical Trials, Phase III as Topic
1
2021
82
0.050
Why?
Infant
1
2014
7959
0.050
Why?
Inulin
1
2021
6
0.050
Why?
Fructokinases
1
2021
29
0.050
Why?
Drinking
1
2021
33
0.050
Why?
Hep G2 Cells
1
2021
60
0.050
Why?
Serum Albumin
1
2021
137
0.050
Why?
Uricosuric Agents
1
2020
1
0.050
Why?
Diuretics, Osmotic
1
2020
1
0.040
Why?
Cell Hypoxia
1
2021
220
0.040
Why?
Mendelian Randomization Analysis
1
2020
43
0.040
Why?
Mice, Inbred C57BL
2
2021
4692
0.040
Why?
Diastole
1
2020
130
0.040
Why?
Systole
1
2020
171
0.040
Why?
Netherlands
1
2019
64
0.040
Why?
Chemokines
1
2021
216
0.040
Why?
Cytoprotection
1
2019
51
0.040
Why?
Drug Interactions
1
2021
338
0.040
Why?
Preoperative Period
1
2019
103
0.040
Why?
Magnetic Resonance Imaging, Cine
1
2020
172
0.040
Why?
Fibrosis
1
2021
453
0.040
Why?
Incretins
1
2018
15
0.040
Why?
Macular Edema
1
2018
34
0.040
Why?
Photography
1
2018
89
0.040
Why?
Renal Elimination
1
2018
6
0.040
Why?
Inflammation Mediators
1
2021
477
0.040
Why?
Xanthine Oxidase
1
2018
71
0.040
Why?
Renal Dialysis
1
2021
374
0.040
Why?
HSP70 Heat-Shock Proteins
1
2018
61
0.040
Why?
Proof of Concept Study
1
2017
47
0.040
Why?
Diet Therapy
1
2018
36
0.040
Why?
Tomography, Optical Coherence
1
2018
130
0.040
Why?
Anti-Obesity Agents
1
2018
45
0.040
Why?
Proteinuria
1
2017
77
0.040
Why?
Cardiovascular System
1
2019
125
0.040
Why?
Lipoproteins, LDL
1
2017
128
0.040
Why?
Blood Pressure Monitoring, Ambulatory
1
2017
61
0.040
Why?
Renal Plasma Flow, Effective
1
2016
1
0.040
Why?
Interleukin-6
1
2021
676
0.030
Why?
Infusions, Intravenous
1
2018
371
0.030
Why?
Thiazolidinediones
1
2018
142
0.030
Why?
Proportional Hazards Models
1
2019
1075
0.030
Why?
Age Distribution
1
2017
342
0.030
Why?
Sex Distribution
1
2017
337
0.030
Why?
Collagen
1
2018
415
0.030
Why?
Waist Circumference
1
2015
122
0.030
Why?
Blood Glucose Self-Monitoring
1
2019
504
0.030
Why?
Combined Modality Therapy
1
2018
1121
0.030
Why?
Circadian Rhythm
1
2017
354
0.030
Why?
Mice, Knockout
1
2021
2568
0.030
Why?
Exercise Therapy
1
2018
351
0.030
Why?
Heart Ventricles
1
2018
712
0.030
Why?
Peptides
1
2018
848
0.030
Why?
Rats, Sprague-Dawley
1
2017
2218
0.030
Why?
Comorbidity
1
2017
1448
0.030
Why?
Databases, Factual
1
2017
1125
0.030
Why?
Gene-Environment Interaction
1
2014
183
0.030
Why?
Models, Statistical
1
2015
599
0.020
Why?
Non-alcoholic Fatty Liver Disease
1
2014
245
0.020
Why?
Magnetic Resonance Imaging
1
2020
3044
0.020
Why?
Hospitalization
1
2017
1750
0.020
Why?
Algorithms
1
2015
1467
0.020
Why?
Neoplasms
1
2014
2097
0.010
Why?
Bjornstad's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)